Patentable Subject Matter: Comparison between French and Jordanian Laws

Iriqat Mohammed

doi:10.6000/2371-1655.2015.01.11

Authors

Iriqat Mohammed Alquds University, Main Campus, Abu Dis, P.O Box 89, Palestine

DOI:

https://doi.org/10.6000/2371-1655.2015.01.11

Keywords:

Intellectual property rights, Innovation, Patent, Trips Agreement, Business Method, Discoveries

Abstract

The purpose of this study is to make a comparison between the patentable subject matter in French and Jordanian law in order to extract the similarities and differences to establish basic principles for Palestine. The Jordanian law is selected as it is in general the law that is applied in Palestine.

Palestine is the only country in the Middle East that does not have legislations protecting intellectual property rights. However, there are sporadic laws applied in Palestine, such as the Ottomans’ law in 1910 related to copyright law and the Jordanian trademark 1952 and patent law in 1953. In 1995 the Palestinian Authority approved some legislation in the field of private law, such as civil and commercial law, but without including in it intellectual property legislation. The term intellectual property is not popular among Palestinian legislators as there are among them few experts in this field.

References

Abbott F, 2004. “The Doha Declaration on the TRIPS Agreement and Public Health and the Contradictory Trend in Bilateral and Regional Free Trade Agreements”, Occasional Paper 14, Quaker United Nations.

Abughet M, 2003. “The legal protection of computer programs“. Aladl Law Review, 45(3):327-348.

Alnahi E, 2000. “ABC commercial and industrial property“. Amman: Dar Alfqr.

Azema J, Galloux J, 2006. “Industrial property law“. Paris: Litec.

Barton J, 2000. “Reforming the patent system Science “. Journal Of Law, 13: 287-292.

Bodenhausen G.H.C., 1968. “Guide to the Application of the Paris Convention for the Protection of Industrial Property”. United International Bureaux for the Protection of Intellectual Property.

Caillaud B, 2003. “Intellectual property rights in software“, London economic school press.

Carl R, 1997. “International dimensions of patent law as it pertains to animal and agricultural biotechnology”. Animal Biotechnology, 8:81-89. http://dx.doi.org/10.1080/10495399709525870

Cassier M, 2008. “Patents and public health in France. Pharmaceutical patent law in- the-making at the patent office between the two world wars”. History and Technology: An International Journal, 24:135-151. http://dx.doi.org/10.1080/07341510701810930

Delcorde A., 1985. “The protection of inventions“. Industrial Property Law Review, 3: 180-195.

Draft Council Regulation on a Community Patent, EU Council document, 2004, http://register.consilium.eu.int/pdf/en/04/ st07/st07119.en04.pdf

Dulian F, 2010. “Industrial property law“. Paris: Dalouz.

European Patent Convention, 1973. https://www.epo.org/law-practice/legal-texts/epc.html

French intellectual property code, 1992, http://www.wipo.int/wipolex/ en/details.jsp?id=5563

Galloux J, 2006, “industrial property law“. Paris: Dalouz.

Hansen B, 1997.“Protecting inventions in chemistry. Commentary on chemical case law under the European Patent Convention and the German Patent Law, “ WILEY-VCH,W einheim.

Hjerbe L, 2003.“U.S. Patent and Trademark Office”. Legal Reference Services Quarterly, 22:53-65. http://dx.doi.org/10.1300/J113v22n01_06

Hunt R, 2004. “Patentability, Industry Structure, and Innovation”. The Journal of Industrial Economics, 52:401-425. http://dx.doi.org/10.1111/j.0022-1821.2004.00232.x

Jackson B, 2003. “Innovation and intellectual property: The case of genomic patenting”. Journal of Policy Analysis and Management, 22:5-25. http://dx.doi.org/10.1002/pam.10093

Kica E & Groenendijk N, 2011. “The European Patent system: dealing with emerging technologies”. Innovation: The European Journal of Social Science Research, 13:85-105. http://dx.doi.org/10.1080/13511610.2011.571405

Korenko G, 2005.“Intellectual Property Protection and Industrial Growth”. The Journal of World Intellectual Property, 4:47-75. http://dx.doi.org/10.1111/j.1747-1796.1999.tb00051.x

Lestanc C, 2009. “Exclusions from patentability“. JurisClasseur, Industrial property law.

Love J., 2006. “Four Practical Measures to Enhance Access to Medical Technologies”, in Negotiating Health. Intellectual Property and Access to Medicines(editors Roffe P., Tansey G., and Vivas-Eugui D.), London: Earthscan.

Luc J, 2003. “Intellectual property law “. Paris: Litec.

Jordan Patent law, 1953. http://www.wipo.int/wipolex/en/profile.jsp? code=JO

Mousseron J, 1984. “patent treaty“. Paris:Litec.

Musungu S.F., 2008. “The TRIPS Agreement and Public Health”, in Intellectual Property and International Trade: The TRIPS Agreement (editors Correa C. and Yusuf A.), Kluwer Law Journal 14:115-122.

Nicolas B, 2012. “Intellectual property law in France”. Sorbonne Legal Journal. 56:232-240.

Quinn E & Miller K, 2011. “'Understanding Patents”. Legal Reference Services Quarterly, 20:85-110. http://dx.doi.org/10.1300/J113v20n04_04

Samuel B, 2005. “Industrial property law”, Paris: L.G.D.J.

Schmidt J, 2010. “Intellectual Property and Competition Law“. Intellectual property Law Review 43:245-368

Vaillard S, Lemercier L, 2011. “Limitation of patents in France” Paris: Litec.

UPOV Convention, 1991, International Union for the Protection of New Varieties of Plants http://www.upov.int/upovlex/en/ upov_convention.html

Vivant M, 2005. “Patent law “.Journal of Law, 30: 71-91.

(TRIPS), 1995, Agreement on Trade-Related Aspects of Intellectual Property Rights https://www.wto.org/english/tratop_e/trips_e/ trips_e.htm

Wagner S, 2008. “Business Method Patent in Europe and Their Strategic Use- Evidence from Franking Device Manufactures”. Economics of Innovation and New Technology, 17:173-194. http://dx.doi.org/10.1080/10438590600984042